Helius Medical Technologies, Inc. (HSDT)
NASDAQ: HSDT · Real-Time Price · USD
4.270
+0.106 (2.56%)
May 16, 2025, 4:00 PM - Market closed
HSDT Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 0.39 | 0.48 | 0.61 | 0.78 | 0.49 | 0.66 | Upgrade
|
| Other Revenue | 0.04 | 0.04 | 0.04 | 0.01 | 0.03 | - | Upgrade
|
| Revenue | 0.43 | 0.52 | 0.64 | 0.79 | 0.52 | 0.66 | Upgrade
|
| Revenue Growth (YoY) | -35.03% | -19.25% | -18.17% | 50.77% | -21.03% | -55.82% | Upgrade
|
| Cost of Revenue | 0.58 | 0.58 | 0.58 | 0.46 | 0.3 | 0.39 | Upgrade
|
| Gross Profit | -0.15 | -0.06 | 0.06 | 0.32 | 0.22 | 0.27 | Upgrade
|
| Selling, General & Admin | 10.48 | 10.12 | 9.27 | 10.64 | 12.18 | 9.53 | Upgrade
|
| Research & Development | 3.82 | 3.66 | 2.94 | 4.26 | 5.99 | 4.58 | Upgrade
|
| Operating Expenses | 14.31 | 13.8 | 12.33 | 15.08 | 18.37 | 14.48 | Upgrade
|
| Operating Income | -14.46 | -13.86 | -12.27 | -14.76 | -18.14 | -14.2 | Upgrade
|
| Interest Expense | -0.02 | -0.02 | - | -0.93 | - | - | Upgrade
|
| Interest & Investment Income | 0.02 | - | 0.26 | 0.1 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0.67 | -1.01 | 0.28 | -0.76 | 0.01 | 0.19 | Upgrade
|
| Other Non Operating Income (Expenses) | 2.1 | 3.18 | 3.05 | 3.03 | - | 0.07 | Upgrade
|
| EBT Excluding Unusual Items | -13.02 | -11.7 | -8.69 | -13.32 | -18.13 | -13.95 | Upgrade
|
| Impairment of Goodwill | - | - | - | -0.76 | - | - | Upgrade
|
| Asset Writedown | -0.04 | -0.04 | -0.16 | - | - | -0.18 | Upgrade
|
| Pretax Income | -13.06 | -11.74 | -8.85 | -14.07 | -18.13 | -14.13 | Upgrade
|
| Net Income | -13.06 | -11.74 | -8.85 | -14.07 | -18.13 | -14.13 | Upgrade
|
| Net Income to Common | -13.06 | -11.74 | -8.85 | -14.07 | -18.13 | -14.13 | Upgrade
|
| Shares Outstanding (Basic) | 0 | 0 | 0 | 0 | - | - | Upgrade
|
| Shares Outstanding (Diluted) | 0 | 0 | 0 | 0 | - | - | Upgrade
|
| Shares Change (YoY) | 554.74% | 345.77% | 125.21% | - | - | - | Upgrade
|
| EPS (Basic) | -44.59 | -65.00 | -218.38 | -781.99 | - | - | Upgrade
|
| EPS (Diluted) | -44.61 | -65.00 | -218.40 | -781.99 | - | - | Upgrade
|
| Free Cash Flow | -11.58 | -11.05 | -10.45 | -14.33 | -13.44 | -11.8 | Upgrade
|
| Free Cash Flow Per Share | -39.51 | -61.15 | -257.74 | -796.17 | - | - | Upgrade
|
| Gross Margin | -33.64% | -11.92% | 9.47% | 41.17% | 42.91% | 41.30% | Upgrade
|
| Operating Margin | -3331.34% | -2665.96% | -1905.12% | -1875.35% | -3475.48% | -2148.56% | Upgrade
|
| Profit Margin | -3010.14% | -2258.08% | -1374.22% | -1788.06% | -3473.56% | -2137.67% | Upgrade
|
| Free Cash Flow Margin | -2667.28% | -2124.23% | -1621.89% | -1820.46% | -2575.10% | -1785.32% | Upgrade
|
| EBITDA | -14.41 | -13.8 | -12.11 | -14.5 | -17.83 | -13.72 | Upgrade
|
| D&A For EBITDA | 0.05 | 0.06 | 0.16 | 0.26 | 0.31 | 0.48 | Upgrade
|
| EBIT | -14.46 | -13.86 | -12.27 | -14.76 | -18.14 | -14.2 | Upgrade
|
| Revenue as Reported | 0.43 | 0.52 | 0.64 | 0.79 | 0.52 | 0.66 | Upgrade
|
| Advertising Expenses | - | 0.65 | 0.67 | - | - | - | Upgrade
|
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.